For newly diagnosed diabetes patients, understanding their condition and managing it can be scary and overwhelming and that can be especially true of children. To ease a bit of the headache, many ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

The Trump administration’s recent changes to the H-1B visa application process are causing concern among healthcare experts, with many worried that the plan could make the industry’s workforce crisis ...

Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, on Tuesday announced the close of a sizable funding round — one that includes about a ...

Provider organizations are continuing to adopt AI tools across their departments and clinics, and ambient documentation startups are facing the challenge of differentiating themselves in a field ...

The Radiological Society of North America is hosting its annual meeting in Chicago this week, bringing together clinicians and tech professionals from all across the globe to share ideas and showcase ...

On Wednesday, Computer Programs and Systems, Inc. (CPSI) sold American HealthTech — its subsidiary that provides an EHR platform for the post-acute care market — to post-acute health IT vendor ...

Eli Lilly is acquiring Sigilon Therapeutics, its type 1 diabetes partner, in a small deal that could pay out big later if the cell therapy developer achieves goals that show it has overcome an immune ...

Hair loss caused by alopecia areata now has a new FDA-approved treatment, a third-in-class drug from Sun Pharmaceutical Industries that will compete against commercialized medicines from Eli Lilly and ...